You are here
AdvaMed Statement on TPP Negotiations
WASHINGTON, D.C. – Stephen J. Ubl, president and CEO of the Advanced Medical Technology Association (AdvaMed), issued the following statement on the conclusion of the TransPacific Partnership (TPP) negotiations:
“AdvaMed applauds the negotiators of the TransPacific Partnership (TPP) for their tireless efforts to successfully conclude this agreement. The potential significance of this agreement on the global economy is tremendous, given that the twelve TPP countries comprise 40 percent of the world’s economy and one-third of global trade.
“Throughout the negotiations, AdvaMed has strongly supported the conclusion of a high-standard TPP agreement that includes provisions promoting regulatory coherence as well as transparency and procedural fairness for medical technology.
“AdvaMed looks forward to learning the details of the final agreement and assessing its impact on the ability of medical technology manufacturers to provide safe and effective products to patients throughout the TPP region.”